Scientific publications

Discover the latest research using Olink’s panels for protein biomarker discovery through our comprehensive list of publications. Easily find relevant studies by filtering them or using the free-text search. Access abstracts, PubMed entries, and full-text papers directly through the links provided.

Filter

Filters

Publication

Disease Area

Application Area

Sample Type

Products

International Journal of Radiation OncologyBiologyPhysics, 2026 Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer Lin S., Pugh S., Valle D. et al.
Experimental Gerontology, 2026 Proteomic signatures of systemic inflammation in aging, multimorbidity, and mortality Jiang Z., Ling D., Chen Z. et al.
Cell Death & Disease, 2026 A pro-inflammatory metastasis-associated macrophage subset induces tumor-promoting mesothelial cell conversion in ovarian cancer via IL-1α secretion Heidemann S., Finkernagel F., Steitz A. et al.
PLOS Medicine, 2026 Protein mediators of chronic kidney disease in Type 2 diabetes: A mendelian randomization study Liang K., Zheng T., Tan D. et al.
International Journal of Molecular Sciences, 2026 Integrative Proteogenomics and Single-Cell Transcriptomics Prioritize Candidate Causal Proteins and Therapeutic Targets in Age-Related Macular Degeneration Wen L., Li F., Liu Y. et al.
Inflammation, 2026 Targeting E-Selectin and ICAM1 Suppresses Endometriosis Progression by Disrupting the Inflammation–Fibrosis Axis and Reducing Local M2 Macrophage Infiltration Wu Y., Ye X., Zheng A. et al.
Nature Metabolism, 2026 Paediatric proteomic signatures of cardiometabolic disease-associated traits predict adult disease outcomes Landman J., Highland H., Perry A. et al.
Clinical and Translational Medicine, 2026 Bevacizumab plus nab‐paclitaxel and platinum as second‐line therapy for driver‐gene‐negative non‐squamous non‐small cell lung cancer after immunochemotherapy: A prospective single‐arm single‐centre study Lin Y., Yu Y., Hu Z. et al.
European Journal of Medical Research, 2026 Strong molecular regulation of PARK7 with limited causal evidence for lung squamous cell carcinoma susceptibility: an integrative reanalysis Li X., Zhang F., Li Y. et al.
Journal of Anatomy, 2026 Immune proteomic associations with indices of cortical development in 5‐year‐old children Barron A., Rosberg A., Tuulari J. et al.
Heart & Lung, 2026 Glucagon-like peptide-1 receptor activation, inflammation and heart failure: Insights from genetic analysis Tian Y., Sheng C., Zhu J. et al.
GeroScience, 2026 Parental longevity and polygenic longevity scores in relation to ageing-related factors in a population of 70-year-olds followed over six years: The Gothenburg H70 Birth Cohort Study Seidu N., Rydén L., Skoog J. et al.
Thorax, 2026 Markers of microvascular instability predict severity and survival in idiopathic pulmonary fibrosis Csordas D., Ma S., Huang Y. et al.
ERJ Open Research, 2026 Circulating proteins in common variable immunodeficiency with granulomatous lymphocytic interstitial lung disease – A Nordic cross-sectional multi-centre study Fraz M., Michelsen A., Hol H. et al.
Nature Communications, 2026 Evaluating the consequences of childhood adiposity on the human plasma proteome at four timepoints across the lifecourse Dickson P., Power G., Niu L. et al.
Nutrition and Health, 2026 Natural reduced water alters circulating immune-related protein profiles in healthy middle-aged adults: An exploratory proteomic analysis Soga K., Shinada T., Takahashi M. et al.
Frontiers in Immunology, 2026 Unsupervised proteomic stratification of people living with HIV reveals inflammatory biotypes beyond conventional clinical classifications Rallón N., Restrepo C., Manquillo A. et al.
Proteomes, 2026 A Circulating Proteomic Signature of Allostatic Load Is Associated with Multisystem Disease and Mortality Guan Y., Shen J., Li L. et al.
International Journal of Molecular Sciences, 2026 Peripheral Immune Modulation in Atopic Dermatitis During Dupilumab or Baricitinib Treatment Is Limited, as Assessed by Proteomic, Transcriptomic, and Torque Teno Virus Analyses Touborg T., Frølunde A., Litman T. et al.
PROTEOMICS – Clinical Applications, 2026 Large‐Scale Plasma Proteomics Reveals Preclinical Biomarkers of Incident Severe Liver Disease Zhao S., Guo C., Zhang X. et al.

4555 publications

Items per page

61-80 of 4555 publications

of 228 pages

Scientific publications

APASL-ACLF without previous decompensation is immunologically distinct from EASL-CLIF-ACLF with previous decompensation

Efficacy and safety of 20% and 100% autologous serum eye drops in patients with severe dry eye disease: a prospective, blinded, randomized, crossover study

Proteomic profiling of liver and plasma uncovers biomarkers and mechanisms in patients with primary biliary cholangitis

Plasma heart-type fatty acid-binding protein, omega-3 fatty acids and adverse cardiac events in the general population

Risk Prediction of Incident Chronic Kidney Disease Using Plasma Proteomics in Individuals Without Diabetes

Olink proteomics identifies a diagnostic signature for unstable angina and predictive biomarkers for in-stent restenosis

SARS-CoV-2-specific monoclonal antibody AER002 in Long COVID: an exploratory randomized phase 2a mechanistic trial

Cytokine Concentrations in Seminal Plasma and Blood in HIV Infection: Differential Modulation by Antiretroviral Therapy and Association with HIV RNA Levels and CD4+T Cell Count